InvestorsHub Logo
Followers 47
Posts 3929
Boards Moderated 0
Alias Born 03/04/2012

Re: None

Friday, 11/04/2022 8:35:18 PM

Friday, November 04, 2022 8:35:18 PM

Post# of 402749
I see Lots of CEO bashing continues... yet Leo hasn't resorted to penny rag promo for many years, nor has he diluted past 488M as of today. It would be easier to pin the slime ball label if he did either of those, but he hasn't.

We don't know what's been discussed or negotiated after he published the payer analysis for B-OM in July.

Speculation is that Leo hasn't yet gotten an OM partnership package he could say yes to, whether BDD brokered or otherwise.

Longs are waiting for Leo to say yes to an offer in order to proceed with Ph- 3 OM.

Meanwhile, major research institutions continue to study and tout Brilacidin's potential for a wide array of pathogens. Each new paper published adds to B's potential value, and it's up to Leo to monetize that value, and get it done.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News